Moral Psychology and the Intuition that Pharmaceutical Companies Have a ‘Special’ Obligation to Society

Huebner, James M.

doi:10.1007/s10551-013-1773-4

Cited by 20 publications

(11 citation statements)

References 50 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Although there is significant research in the ethics of care in education, nursing and social work, Kujala et al (2011) were the first to use ethics of care to account for the fact that ethical decision-making has become more multidimensional while acknowledging that utilitarianism has been the dominant moral theory over time. Huebner (2014) questions the traditional notion of whether the pharmaceutical sector has a unique obligation to society. He questions traditional ideologies that pharmaceutical companies have a moral obligation of beneficence (caring), especially for the impoverished.…”

Section: Ethics Of Carementioning

confidence: 99%

An analysis of the ethical frameworks and financial outcomes of corporate social responsibility and business press reporting of US pharmaceutical companies

LaVan

Cook

Žilić

2021

IJBGE

View full text Add to dashboard Cite

We use content analysis to discern ethical patterns of communication differences between the business press and corporate social responsibility (CSR) reports in the US pharmaceutical sector. The methodology is based on content analysis of documents in the public domain, rather than based on surveys or interviews of other empirical work, allowing for replication and transparency. The qualitative and statistical analysis of our data indicates that there are statistically significant differences between how CSR is communicated in the business press and in the CSR documents themselves. However, there was not a statistical relationship between having a formal CSR report and financial outcome as measured by return on assets. The results indicate that individuals and organisations charged with communicating the organisations' activities should be cognisant of where there are differences and should develop communication processes to assure the company is disseminating the correct message in the reporting of their CSR activities.

show abstract

Section: Ethics Of Carementioning

confidence: 99%

An analysis of the ethical frameworks and financial outcomes of corporate social responsibility and business press reporting of US pharmaceutical companies

LaVan

Cook

Žilić

2021

IJBGE

View full text Add to dashboard Cite

show abstract

“…One could therefore ask to what extent does the 'Good Samaritan intuition' (Huebner, 2014) that those who create wealth have a moral obligation to help those who are less privileged apply in the pharmaceutical industry?…”

Section: Social Responsibilities Of Pharmaceutical Companiesmentioning

confidence: 99%

Digital Reflections of Pharmaceutical Companies and their CSR Communication Strategies

Grigore¹,

Adi²,

Theofilou³

2015

Developments in Corporate Governance and Responsibility

View full text Add to dashboard Cite

Purpose À Taking into consideration that the number of reports about pharmaceutical lobbying activities is increasing (Baleta, 2014;Boseley, 2014) and that the cost of drugs has a direct and powerful impact on both public and private healthcare, there is a need to require pharmaceutical companies to report their activity as well as reflect their considerations about the ethical implications of their work. To answer that need, this chapter explores how pharmaceutical companies communicate their corporate social responsibility activities.Methodology/approach À This chapter explores how Pfizer, GlaxoSmithKline and Sanofi (all in the top 10 of US foundations by total giving) use their websites to articulate their CSR strategies. In order to achieve this goal, an exploratory research that combines Corporate Social Responsibility in the Digital Age Developments in Corporate Governance and Responsibility, Volume 7, 221À239Practical implications and originality/value À This chapter promotes an alternative exploratory method of online discourses through computeraided techniques.

show abstract

“…Ethical reform of pharmaceutical companies is a dire need. There exists a nearly universal moral outrage in response to the industry's deceptive and unlawful business practices and it remains an open question whether direct advertising to the consumer (DTCA) by the pharmaceutical companies can effectively regulate them in accordance with the societal expectations (Huebner, 2014). The study of ethical behaviour of pharmaceutical companies is considered important not only because of the economic significance but also because of its impact on the health and well-being of people of all ages and at all economic levels (Sillup and Porth, 2008).…”

Section: Introductionmentioning

confidence: 99%

Understanding ethical/unethical behavior in pharmaceutical companies: a literature review

Marmat

Jain

Mishra

2020

IJPHM

View full text Add to dashboard Cite

Purpose The purpose of this paper is to examine and review the available literature on ethical/unethical behaviour of pharmaceutical companies and to determine the ethical issues, unethical behaviour by analysing, summarising and categorising the factors related to these issues and unethical behaviour as were studied during the period 2008-2017. Essentially, this paper presents a critical analysis of the available literature on the subject and avenues for future research. Design/methodology/approach This paper adopted the systematic review approach to achieve the purpose of this study and examines the most relevant literature from online existing database sources, available between 2008-2017 by using the keyword search method. Then studies are categorised and summarised, using previously developed theories and frameworks, which have provided evidence to the universal consensus that ethical behavioural outcomes are dependent on the interplay of individual, organisational and environmental factors and have reordered to fulfil the purpose. Findings The findings identify that ethical issues related to pharmaceutical companies as were studied during the period 2008-2017 are drug pricing, drug safety and gift-giving. The organisational variables appeared to be the dominant cause of these ethical issues and unethical practices along with other determinants such as environmental and stakeholders. A large number of studies were in the western country context. Theoretical research has studied more comparatively empirical studies. Research limitations/implications This review provides insights for understanding the ethical issues, unethical behaviour and determinants related to these issues of pharmaceutical companies and provides insights where the literature is standing. This review only includes studies between 2008-2017, which are related to the ethical issue of pharmaceutical companies, therefore, the view is only of the past 10 years papers. This review provides gaps and insight into the source of ideas for future research and will help the researchers in guiding ethics-related information in the context of pharmaceutical companies. Practical implications This study will help the practitioners and policymakers in informing about the issues that required the urgent need to solve and will shed some light to focus and formulate strategies for successful competitive advantage. This study will help researchers who are seeking information related to ethics and ethical behaviour in pharmaceutical companies. Originality/value To the best of my knowledge, this review of understanding ethical/unethical behaviour in pharmaceutical companies of the past 10 years between 2008-2017 has not been done to date. This study is filling the gap by bringing all the information about ethics in pharmaceutical companies at one place, which works as an index of ethics-related study in this specific pharmaceutical company context.

show abstract

Moral Psychology and the Intuition that Pharmaceutical Companies Have a ‘Special’ Obligation to Society

Cited by 20 publications

References 50 publications

An analysis of the ethical frameworks and financial outcomes of corporate social responsibility and business press reporting of US pharmaceutical companies

An analysis of the ethical frameworks and financial outcomes of corporate social responsibility and business press reporting of US pharmaceutical companies

Digital Reflections of Pharmaceutical Companies and their CSR Communication Strategies

Understanding ethical/unethical behavior in pharmaceutical companies: a literature review

Contact Info

Product

Resources

About